诊断心电图市场 - 全球产业规模、份额、趋势、机会及预测（依产品类型、通路、最终用途、地区及竞争格局划分，2021-2031年）

全球诊断心电图市场预计将从 2025 年的 84.8 亿美元成长到 2031 年的 128.1 亿美元，复合年增长率为 7.12%。

这些设备旨在捕捉并记录特定时间内的心臟电活动，是检测心肌梗塞和心律不整等心臟异常的重要工具。推动该市场发展的主要经济因素是全球心血管疾病盛行率的上升，这使得频繁且准确的心臟监测对于有效的患者照护至关重要。此外，儘管技术不断进步，但老年人口的增长（老年人更容易患慢性心臟疾病）仍持续推动着对这些诊断设备的基本需求。

儘管成长指标强劲，但由于缺乏能够准确解读复杂心电图结果的熟练医务人员，该行业仍面临许多挑战。这可能导致诊断瓶颈，阻碍高效率的工作流程。鑑于需要治疗的患者数量庞大，医疗保健系统承受着巨大的压力。根据美国心臟协会预测，到2024年，美国将有约1.269亿成年人患有某种形式的心血管疾病。如此巨大的疾病负担凸显了对便捷的诊断解决方案和训练有素的医务人员进行有效诊疗的迫切需求。

市场驱动因素

将人工智慧 (AI) 和机器学习技术应用于心电图判读，正在成为市场上的变革力量，从根本上改变了诊断流程和可近性。这些技术透过自动检测复杂心律不整，提高了临床诊断的准确性和速度，从而缓解了专科医生严重短缺的问题，同时也促进了先进诊断工具在非医院环境中的应用。这项技术进步正在迅速扩展硬体的功能。例如，Healio 在 2024 年 6 月报道称，FDA 已核准一款新型的 AI 赋能携带式12 导联心电图系统，该系统能够区分 35 种不同的心臟观察，显着提升了携带式设备在即时应用中的诊断效用。

同时，穿戴式和携带式心电图监测设备的快速普及，透过实现持续的远端心电图监测，正在改变患者照护方式。这一趋势推动了整个行业向门诊护理的转变，使医疗系统能够在维持严格监测标准的同时，降低与长期住院相关的成本。这些远端解决方案的临床和经济价值是市场上的关键差异化因素。皇家飞利浦公司2024年5月发布的新闻稿重点介绍了一项研究，该研究表明，使用行动门诊心臟遥测的患者再入院率（30.2%）显着低于使用植入式循环记录仪的患者（35.4%）。随着心臟护理经济影响的不断扩大，这种效率的提升至关重要。美国心臟协会在2024年预测，到2050年，美国与心血管疾病相关的年度医疗费用将增加近四倍，达到1.49兆美元。

市场挑战

熟练医疗专业人员的短缺是诊断性心电图市场成长的主要阻碍因素。儘管对心臟监测的需求不断增长，但由于训练有素的技术人员和心臟病专家的短缺，处理和解读诊断数据的能力受到限制。这种短缺造成了营运瓶颈，患者吞吐量受限于结果分析的速度，而非设备的可用性。因此，医疗机构可能会推迟购买额外的心电图设备，因为在人员没有相应增加的情况下增加硬体库存并不能转化为患者管理整体效率的提高。

诊断程序需求量与可用医护人员数量之间的不平衡直接影响市场收入。医院被迫优先处理现有病例，而非投资扩充设备，导致设备更新週期延长，采购率降低。近期行业数据也印证了这项医护人员短缺问题的严重性。 2024年，美国医学院协会（AAMC）报告称，预计到2036年，美国将面临高达8.6万名医生的缺口。专科医务人员的持续短缺凸显了复杂诊断能力的不足，从而限制了製造商的潜在市场规模。

市场趋势

智慧型手机连接的便携式心电图仪正从消费级医疗保健领域向严谨的临床应用领域发展，利用大型数据集实现医疗级精准度。这些设备透过采用与传统12导联繫统相媲美的深度学习模型，将先进的诊断功能直接赋予患者，从而改变全球诊断心电图市场。这种能力的提升得益于海量心臟数据的积累，这些数据不断优化检测演算法，使其能够即时应用于临床诊疗。根据《心血管商业》（Cardiovascular Business）2024年6月的一篇报导报道，新核准的KAI 12L技术基于超过175万份心电图进行训练，使这款携带式设备能够识别包括心肌梗塞在内的多种疾病。

同时，随着製造商克服讯号杂讯和资料过载等历史难题，无线和无导线心电图架构（尤其是植入式心臟监视器 (ICM)）的普及速度正在加快。与传统的外部贴片和有线动态心电图监测不同，这些无导线植入可提供长期皮下监测，但以往却因大量误报而给临床医生带来负担。近期技术进步已将先进演算法直接整合到这些无导线设计中，透过在传输前过滤非临床伪影来提高诊断准确性和操作效率。例如，《心臟节律新闻》在2024年4月报道，采用SmartECG技术的新型Biomonitor IV植入式心臟监视器可整体主要心律不整的误报率降低86%，从而显着简化医疗团队的审查流程。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球诊断心电图市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（静态心电图设备、动态心电图设备、心电图监测、其他）
  • 按通道数（12通道、6通道、5通道、3通道、单通道）
  • 依用途（医院/诊所、门诊手术中心、心臟护理中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美诊断心电图市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲诊断心电图市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区诊断心电图市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲诊断心电图市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲诊断心电图市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球诊断心电图市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• General Electric Company
• Koninklijke Philips NV
• Nihon Kohden Corporation
• Ambu A/S
• Spacelabs Healthcare, Inc.
• AliveCor, Inc.
• Mindray Medical India Pvt. Ltd.
• Hill-Rom Holdings, Inc.
• Bpl Medical Technologies Pvt. Ltd.
• Bardy Diagnostics, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Diagnostic Electrocardiograph Market is projected to expand from USD 8.48 Billion in 2025 to USD 12.81 Billion by 2031, registering a CAGR of 7.12%. These devices, designed to capture and record the heart's electrical activity over specific durations, serve as essential tools for detecting cardiac abnormalities like myocardial infarctions and arrhythmias. The primary economic force driving this market is the rising global prevalence of cardiovascular diseases, which necessitates frequent and precise cardiac monitoring for effective patient care. Additionally, the growing geriatric population, a demographic statistically more prone to chronic heart conditions, continues to reinforce the fundamental demand for these diagnostic instruments, irrespective of technological advancements.

Despite these strong growth indicators, the industry faces a substantial hurdle due to a shortage of skilled healthcare professionals qualified to accurately interpret complex electrocardiogram results, which can cause diagnostic bottlenecks and hinder efficient workflows. This strain on healthcare systems is significant considering the high volume of patients requiring attention. As reported by the American Heart Association in 2024, approximately 126.9 million adults in the United States were living with some form of cardiovascular disease. This immense disease burden highlights the critical need for accessible diagnostic solutions and a trained workforce to manage the caseload effectively.

Market Driver

The integration of Artificial Intelligence and Machine Learning into ECG interpretation represents a transformative force in the market, fundamentally changing diagnostic workflows and accessibility. These technologies help mitigate the critical shortage of specialists by automating the detection of complex arrhythmias, thereby improving clinical accuracy and speed while facilitating the deployment of advanced diagnostic tools in non-hospital environments. This technological progression is rapidly broadening hardware capabilities; for instance, Healio reported in June 2024 that the FDA cleared a new AI-enabled handheld 12-lead ECG system capable of identifying 35 different cardiac determinations, significantly expanding the diagnostic utility of portable devices for immediate clinical use.

Concurrently, the rapid proliferation of wearable and portable ECG monitoring devices is reshaping patient management by enabling continuous, remote cardiac surveillance. This trend supports the industry-wide shift toward ambulatory care, allowing healthcare systems to reduce costs associated with long-term hospitalization while maintaining rigorous oversight standards. The clinical and economic value of these remote solutions is a key market differentiator; a May 2024 press release from Royal Philips highlighted a study showing that patients utilizing mobile cardiac outpatient telemetry had a significantly lower readmission rate of 30.2% compared to 35.4% for those with implantable loop recorders. Such efficiency is vital as the economic impact of heart care grows, with the American Heart Association projecting in 2024 that annual U.S. health care costs for cardiovascular conditions will nearly quadruple to $1,490 billion by 2050.

Market Challenge

The scarcity of skilled healthcare professionals acts as a major constraint on the growth of the diagnostic electrocardiograph market. Although the demand for cardiac monitoring is increasing, the capacity to process and interpret the resulting diagnostic data is limited by a lack of trained technicians and cardiologists. This deficit creates operational bottlenecks where patient throughput is restricted not by device availability, but by the speed of result analysis. Consequently, healthcare facilities may delay purchasing additional electrocardiograph units, as increasing hardware inventories without a corresponding increase in workforce capacity fails to improve overall patient management efficiency.

This imbalance between the volume of required diagnostic procedures and the available workforce directly impacts market revenue. Hospitals are forced to prioritize managing existing caseloads rather than investing in fleet expansion, leading to extended replacement cycles and reduced procurement rates. The severity of this workforce issue is underscored by recent industry data; the Association of American Medical Colleges reported in 2024 that the United States faces a projected shortage of up to 86,000 physicians by 2036. This persistent lack of specialty care providers highlights the limited capacity to handle complex diagnostics, thereby restricting the total addressable market for manufacturers.

Market Trends

The evolution of smartphone-connected handheld ECG devices is shifting beyond consumer wellness into rigorous clinical application, utilizing massive datasets to achieve medical-grade precision. These devices are transforming the Global Diagnostic Electrocardiograph Market by placing sophisticated diagnostic capabilities directly into patients' hands, supported by deep learning models that rival traditional 12-lead systems. This capability is driven by the aggregation of vast amounts of cardiac data which refines detection algorithms for immediate point-of-care use; according to a June 2024 Cardiovascular Business article, the newly approved KAI 12L technology was trained on data from over 1.75 million ECGs, enabling the handheld device to provide determinations for a wide range of conditions, including myocardial infarctions.

Simultaneously, the adoption of wireless and leadless ECG architectures, particularly insertable cardiac monitors (ICMs), is accelerating as manufacturers resolve historical issues regarding signal noise and data overload. Unlike traditional external patches or wired Holter monitors, these leadless implants offer long-term subcutaneous monitoring but have previously burdened clinicians with high volumes of false alerts. Recent advancements now integrate sophisticated algorithms directly into these leadless designs to filter non-clinical artifacts before transmission, enhancing diagnostic yield and operational efficiency. For instance, Cardiac Rhythm News reported in April 2024 that the new Biomonitor IV insertable cardiac monitor features SmartECG technology that reduces false detections by 86% across all major arrhythmias, significantly streamlining the review process for care teams.

Key Market Players

• General Electric Company
• Koninklijke Philips N.V.
• Nihon Kohden Corporation
• Ambu A/S
• Spacelabs Healthcare, Inc.
• AliveCor, Inc.
• Mindray Medical India Pvt. Ltd.
• Hill-Rom Holdings, Inc.
• Bpl Medical Technologies Pvt. Ltd.
• Bardy Diagnostics, Inc.

Report Scope

In this report, the Global Diagnostic Electrocardiograph Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Electrocardiograph Market, By Product Type

• Resting ECG Devices
• Stress ECG Devices
• Holter Monitors
• Others

Diagnostic Electrocardiograph Market, By Channel

• 12-channel
• 6-channel
• 5- channel
• 3- channel
• Single- channel

Diagnostic Electrocardiograph Market, By End Use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Cardiac Care Centers
• Others

Diagnostic Electrocardiograph Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Electrocardiograph Market.

Available Customizations:

Global Diagnostic Electrocardiograph Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diagnostic Electrocardiograph Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Others)
  • 5.2.2. By Channel (12-channel, 6-channel, 5- channel, 3- channel, Single- channel)
  • 5.2.3. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Cardiac Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Diagnostic Electrocardiograph Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Channel
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diagnostic Electrocardiograph Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Channel
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Diagnostic Electrocardiograph Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Channel
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Diagnostic Electrocardiograph Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Channel
      • 6.3.3.2.3. By End Use

7. Europe Diagnostic Electrocardiograph Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Channel
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Diagnostic Electrocardiograph Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Channel
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Diagnostic Electrocardiograph Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Channel
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Diagnostic Electrocardiograph Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Channel
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Diagnostic Electrocardiograph Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Channel
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Diagnostic Electrocardiograph Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Channel
      • 7.3.5.2.3. By End Use

8. Asia Pacific Diagnostic Electrocardiograph Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Channel
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Diagnostic Electrocardiograph Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Channel
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Diagnostic Electrocardiograph Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Channel
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Diagnostic Electrocardiograph Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Channel
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Diagnostic Electrocardiograph Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Channel
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Diagnostic Electrocardiograph Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Channel
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Diagnostic Electrocardiograph Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Channel
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Diagnostic Electrocardiograph Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Channel
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Diagnostic Electrocardiograph Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Channel
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Diagnostic Electrocardiograph Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Channel
      • 9.3.3.2.3. By End Use

10. South America Diagnostic Electrocardiograph Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Channel
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Diagnostic Electrocardiograph Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Channel
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Diagnostic Electrocardiograph Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Channel
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Diagnostic Electrocardiograph Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Channel
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Diagnostic Electrocardiograph Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. General Electric Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Koninklijke Philips N.V.
• 15.3. Nihon Kohden Corporation
• 15.4. Ambu A/S
• 15.5. Spacelabs Healthcare, Inc.
• 15.6. AliveCor, Inc.
• 15.7. Mindray Medical India Pvt. Ltd.
• 15.8. Hill-Rom Holdings, Inc.
• 15.9. Bpl Medical Technologies Pvt. Ltd.
• 15.10. Bardy Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer